Börskollen - Aktier, fonder och ekonominyheter
Börskollen
•Nyhetsbrev: Glädjebesked från regeringen: Stopp för omstridd effektavgift

Pressmeddelanden från Thor Medical

 Bevaka pressreleaser
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts
31 aug 2023 07:00
Thor Medical
Thor Medical ASA first half 2023 results17 aug 2023 15:39
Thor Medical
Invitation to presentation of Thor Medical ASA's first half results 202328 jun 2023 16:30
Thor Medical
Nordic Nanovector – Completion of annual general meeting27 jun 2023 14:45
Thor Medical
Disclosure of proxies for the AGM07 jun 2023 14:46
Thor Medical
Nordic Nanovector - Mandatory notification of trade - primary insider13 maj 2022 07:00
Thor Medical
Nordic Nanovector ASA: Results for the First Quarter 202228 apr 2022 17:11
Thor Medical
Nordic Nanovector ASA: The Annual General Meeting held29 nov 2021 08:00
Thor Medical
Nordic Nanovector ASA: R&D Day to be virtual via live webcast only18 nov 2021 07:04
Thor Medical
Nordic Nanovector ASA: Invitation to attend R&D Day18 nov 2021 07:01
Thor Medical
Nordic Nanovector ASA: Results for the Third Quarter 202118 nov 2021 07:00
Thor Medical
Nordic Nanovector ASA: Resultat for tredje kvartal 202109 nov 2021 17:54
Thor Medical
Nordic Nanovector supports The Health Policy Partnership’s initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma27 aug 2021 07:01
Thor Medical
Nordic Nanovector ASA: Results for the Second Quarter and First Half 202127 aug 2021 07:00
Thor Medical
Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 202120 aug 2021 08:00
Thor Medical
Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2021 Results Presentation Webcast